Gabapentin: Difference between revisions

Revision as of 22:38, 12 February 2014

Gabapentin
NEURONTIN (gabapentin) capsule , NEURONTIN (gabapentin) tablet, film coated , NEURONTIN (gabapentin) solution^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Gabapentin
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information about Gabapentin, click here.

Synonyms / Brand Names: ^®,

Overview

FDA Package Insert

Mechanism of Action

References

Template:Antimigraine preparations

Synonyms / Brand Names: Neurontin

Dosing and Administration

Gabapentin is given orally with or without food. Half-tablets not used within several days of breaking the scored tablet should be discarded.

Postherpetic Neuralgia: a single 300-mg dose on Day 1, 600 mg/day on Day 2 (divided BID), and 900 mg/day on Day 3 (divided TID). The dose can subsequently be titrated up as needed for pain relief to a daily dose of 1800 mg (divided TID).

Epilepsy: For age 12+, 900 to 1800 mg/day in divided dosage, starting at 300mg TID. For ages 3-12, 10–15 mg/kg/day in 3 divided doses, and the effective dose reached by increasing over 3 days. (effective dose for age 5+:25–35 mg/kg/day divided TID; age 3-4: 40 mg/kg/day divided TID)

Dosage in the elderly:Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and dose should be adjusted based on creatinine clearance values in these patients.

FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español

FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Gabapentin

Return to top

Publication Resources

Most Recent Articles on Gabapentin

Review Articles on Gabapentin

Articles on Gabapentin in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Gabapentin

Return to top

Trial Resources

Ongoing Trials with Gabapentin at Clinical Trials.gov

Trial Results with Gabapentin

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Gabapentin

Cochrane Collaboration on Gabapentin

Cost Effectiveness of Gabapentin

Return to top

Media Resources

Powerpoint Slides on Gabapentin

Images of Gabapentin

Podcasts & MP3s on Gabapentin

Videos on Gabapentin

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Gabapentin

Discussion Groups on Gabapentin

Patient Handouts on Gabapentin

Blogs on Gabapentin

Gabapentin in the News

Gabapentin in the Marketplace

Return to top

International Resources

Gabapentin en Español

Return to top

Adapted from the FDA Package Insert.

@@ Line 1: / Line 1: @@
+__NOTOC__
+{{Gabapentin}}
+{{CMG}}; {{AE}} {{PB}}
+'''''For patient information about Gabapentin, click [[Gabapentin (patient information)|here]].'''''
+{{SB}} <sup>®</sup>,
+==Overview==
+==Category==
+==FDA Package Insert==
+'''  [[XXXXX indications and usage|Indications and Usage]]'''
+'''| [[XXXXX dosage and administration|Dosage and Administration]]'''
+'''| [[XXXXX dosage forms and strengths|Dosage Forms and Strengths]]'''
+'''| [[XXXXX contraindications|Contraindications]]'''
+'''| [[XXXXX warnings and precautions|Warnings and Precautions]]'''
+'''| [[XXXXX adverse reactions|Adverse Reactions]]'''
+'''| [[XXXXX drug interactions|Drug Interactions]]'''
+'''| [[XXXXX use in specific populations|Use in Specific Populations]]'''
+'''| [[XXXXX overdosage|Overdosage]]'''
+'''| [[XXXXX description|Description]]'''
+'''| [[XXXXX clinical pharmacology|Clinical Pharmacology]]'''
+'''| [[XXXXX nonclinical toxicology|Nonclinical Toxicology]]'''
+'''| [[XXXXX clinical studies|Clinical Studies]]'''
+'''| [[XXXXX how supplied storage and handling|How Supplied/Storage and Handling]]'''
+'''| [[XXXXX patient counseling information|Patient Counseling Information]]'''
+'''| [[XXXXX labels and packages|Labels and Packages]]'''
+==Mechanism of Action==
+==References==
+{{Reflist|2}}
+{{Antimigraine preparations}}
+[[Category:Drugs]]
 <small>'''''Synonyms / Brand Names:''''' Neurontin</small>
-{{CMG}}
 ==Dosing and Administration==